182 related articles for article (PubMed ID: 29132372)
21. Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1+ Immune Cells.
Kondo Y; Kimura O; Tanaka Y; Ninomiya M; Iwata T; Kogure T; Inoue J; Sugiyama M; Morosawa T; Fujisaka Y; Shimosegawa T
J Virol; 2015 Jul; 89(14):7016-27. PubMed ID: 25926643
[TBL] [Abstract][Full Text] [Related]
22. Ethanol-mediated upregulation of APOA1 gene expression in HepG2 cells is independent of de novo lipid biosynthesis.
Khodja Y; Samuels ME
Lipids Health Dis; 2020 Jun; 19(1):144. PubMed ID: 32563265
[TBL] [Abstract][Full Text] [Related]
23. HBV Upregulates CtBP2 Expression via the X Gene.
Liu X; Zhu C; Li J; Xu F; Huang G; Xu L; Zhang B
Biomed Res Int; 2018; 2018():6960573. PubMed ID: 30151388
[TBL] [Abstract][Full Text] [Related]
24. Elevated expression of bisecting N-acetylglucosaminyltransferase-III gene in a human fetal hepatocyte cell line by hepatitis B virus.
Shim JK; Lee YC; Chung TH; Kim CH
J Gastroenterol Hepatol; 2004 Dec; 19(12):1374-87. PubMed ID: 15610311
[TBL] [Abstract][Full Text] [Related]
25. High expression of beta2-glycoprotein I is associated significantly with the earliest stages of hepatitis B virus infection.
Liu YM; Zhang WY; Wang ZF; Yan CY; Gao PJ
J Med Virol; 2014 Aug; 86(8):1296-306. PubMed ID: 24760738
[TBL] [Abstract][Full Text] [Related]
26. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S
J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660
[TBL] [Abstract][Full Text] [Related]
27. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus].
Yan SN; Deng B; Gong ZJ
Ai Zheng; 2003 May; 22(5):504-7. PubMed ID: 12753712
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
[TBL] [Abstract][Full Text] [Related]
29. Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection.
Sengupta S; Rehman S; Durgapal H; Acharya SK; Panda SK
J Med Virol; 2007 Mar; 79(3):220-8. PubMed ID: 17245717
[TBL] [Abstract][Full Text] [Related]
30. Lack of evidence for a liver or intestinal miRNA regulation involved in the hypertriglyceridemic effect of APOC3 3'UTR variant SstI.
Dancer M; Caussy C; Di Filippo M; Moulin P; Marçais C; Charrière S
Atherosclerosis; 2016 Dec; 255():6-10. PubMed ID: 27794214
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus X protein binding to hepsin promotes C3 production by inducing IL-6 secretion from hepatocytes.
Zhang M; Gu J; Zhang C
Oncotarget; 2016 Feb; 7(7):7780-800. PubMed ID: 26760961
[TBL] [Abstract][Full Text] [Related]
32. Control of hepatitis B virus replication by innate response of HepaRG cells.
Lucifora J; Durantel D; Testoni B; Hantz O; Levrero M; Zoulim F
Hepatology; 2010 Jan; 51(1):63-72. PubMed ID: 19877170
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein C3 is negatively associated with estrogen and mediates the protective effect of estrogen on hypertriglyceridemia in obese adults.
Li J; Sun H; Wang Y; Liu J; Wang G
Lipids Health Dis; 2023 Feb; 22(1):29. PubMed ID: 36855114
[TBL] [Abstract][Full Text] [Related]
34. The role of Moloney leukemia virus 10 in hepatitis B virus expression in hepatoma cells.
Ma YX; Li D; Fu LJ; Fu BQ; Chen SJ; Xu WZ; Teng X; Song ZW; Gu HX
Virus Res; 2015 Feb; 197():85-91. PubMed ID: 25533532
[TBL] [Abstract][Full Text] [Related]
35. Complement C4a inhibits the secretion of hepatitis B virus screened by surface-enhanced laser desorption ionization time-flight mass spectrometry-based ProteinChip analysis.
Song YN; Zhang GB; Hu XQ; Lu YY; Zhao Y; Yang Y; Yang YF; Zhang YY; Hu YY; Su SB
Proteomics Clin Appl; 2015 Dec; 9(11-12):1097-104. PubMed ID: 26119402
[TBL] [Abstract][Full Text] [Related]
36. ANTIVIRAL ACTIVITY OF
Li WG; Wang HQ
Afr J Tradit Complement Altern Med; 2016; 13(5):48-53. PubMed ID: 28487893
[TBL] [Abstract][Full Text] [Related]
37. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
[TBL] [Abstract][Full Text] [Related]
38. Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.
Xia Y; Stadler D; Lucifora J; Reisinger F; Webb D; Hösel M; Michler T; Wisskirchen K; Cheng X; Zhang K; Chou WM; Wettengel JM; Malo A; Bohne F; Hoffmann D; Eyer F; Thimme R; Falk CS; Thasler WE; Heikenwalder M; Protzer U
Gastroenterology; 2016 Jan; 150(1):194-205. PubMed ID: 26416327
[TBL] [Abstract][Full Text] [Related]
39. Increased ATG5-ATG12 in hepatitis B virus-associated hepatocellular carcinoma and their role in apoptosis.
Kunanopparat A; Kimkong I; Palaga T; Tangkijvanich P; Sirichindakul B; Hirankarn N
World J Gastroenterol; 2016 Oct; 22(37):8361-8374. PubMed ID: 27729742
[TBL] [Abstract][Full Text] [Related]
40. Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.
Dusséaux M; Masse-Ranson G; Darche S; Ahodantin J; Li Y; Fiquet O; Beaumont E; Moreau P; Rivière L; Neuveut C; Soussan P; Roingeard P; Kremsdorf D; Di Santo JP; Strick-Marchand H
Gastroenterology; 2017 Dec; 153(6):1647-1661.e9. PubMed ID: 28851562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
